Strategic monitoring of rodenticide residues in Eurasian otters to evaluate the effectiveness of risk mitigation measures in biocide registration

Project description

In the European Union, biocides are officially approved following the EU Biocide regulation No. 528/2012. So far, the following eight anticoagulants were assessed and approved for rodenticide use in the EU: Warfarin, Chlorophacinone, Coumatetralyl, Bromadiolone, Difenacoum, Brodifacoum, Difethialone and Flocoumafen. The first three active ingredients belong to the first-generation anticoagulants, whereas the last five belong tot he second-generation anticoagulants. Second-generation anticoagulant rodenticides (AR) were considered persistent, bioaccumulative and toxic (PBT- or vPvB ingredients) and thus only approved for pest control under very strict regulations, due to the lack of alternative ingredients.

Taking into account the results of previous research projects to investigate the contamination of ARs in fish and the effects of Ars on the aquatic environment, this project aims to evaluate the effectiveness of current risk mitigation measures to reduce contamination of water bodies with Ars by using a biota monitoring approach. A nationwide, strategic monitoring for otters (Eurasian otter, Lutra lutra) will be initiated to evaluate current risk mitigation and to determine relevant exposition for both aquatic and semi-aquatic top predators. In addition, the transfer of active ingredients alongside the aquatic food chain and the metabolism of Ars in fish will be investigated.

The outcome of the project with regards to environmental contamination of aquatic habitats with Ars and the effectiveness of current risk mitigation measures shall allow the funding agency to implement scientifically based decisions in the biocide registration. Also, former decisions might be revised or substantially improved.